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Objective: To explore driving performance and driving safety in patients with cervical
dystonia (CD) on a simulated lane tracking, intersections and highway ride and to
compare it to healthy controls.
Design: This study was performed as an explorative between groups comparison.
Participants: Ten CD patients with idiopathic CD, 30 years or older, stable on botulinum
toxin treatment for over a year, holding a valid driver’s license and being an active driver
were compared with 10 healthy controls, matched for age and gender.
Main outcome measures: Driving performance and safety, measured by various
outcomes from the simulator, such as the standard deviation of the lateral position on the
road, rule violations, percentage of line crossings, gap distance, and number of collisions.
Fatigue and driving effort were measured with the Borg CR-10 scale and self-perceived
fitness to drive was assessed with Fitness to Drive Screening.
Results: Except for a higher percentage of line crossings on the right side of the road
by controls (median percentage 2.30, range 0.00–37.00 vs. 0.00, range 0.00–9.20,
p = 0.043), no differences were found in driving performance and driving safety during
the simulator rides. Fatigue levels were significantly higher in CD patients just before
(p = 0.005) and after (p = 0.033) the lane tracking ride (patients median fatigue
levels before 1.5 (range 0.00–6.00) and after 1.5 (range 0.00–7.00) vs. controls median
fatigue levels before and after 0.00 (no range). No significant differences were found on
self-perceived fitness to drive.
Conclusion: In patients with CD there were no indications that driving performance
or driving safety were significant different from healthy controls in a simulator. Patients
reported higher levels of fatigue both before and after driving compared to controls in
accordance with the non-motor symptoms known in CD.
Keywords: cervical dystonia, driving, driving performance, simulator, daily life tasks
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INTRODUCTION
Cervical Dystonia (CD) is a neurological disorder characterized
by involuntary muscle contractions causing abnormal positions
and involuntary movements of the neck and head. With an
estimated prevalence of 4.9 (CI95% 3.6–6.9) patients per 100,000
persons, it is the most common form of dystonia. (1) Besides
motor symptoms, patients may also suffer from non-motor
symptoms including pain, anxiety, depression, fatigue, and loss of
self-confidence (2, 3). Both motor and non-motor symptoms can
have a major impact on the level of disability causing limitations
in daily life activities (4, 5). The preferred treatment is to inject the
affected neck muscles with Botulinum Toxin (BoNT) injections
which reduces involuntary movements and abnormal postures
in 75–92% of the patients (6). Improvement of motor symptoms
also decrease the level of disability but BoNT treatment is often
not fully satisfactory and many patients still maintain difficulties
while performing daily life tasks.
The ability to drive a vehicle is a very important part of
daily life activities. It is important for social contacts, to get
to work, and to access everyday needs such as goods and
services. Driving a motor vehicle is a complex task requiring
adequate interaction between visual, cognitive, and motor skills.
It is known that a wide range of acute and chronic medical
conditions may impair driving performance and safety (7).
Since CD is characterized by involuntary movements and/or
abnormal postures of the neck, patients may be impaired in
visual scanning of the environment which may affect driving
performance. In clinical practice some patients with CD indicate
to use tricks or operational adaptations in the car, such as
supporting their head while driving or turning their entire torso
to the required direction before crossing an intersection. It is
conceivable that patients also apply compensatory actions on a
tactical level during driving, such as lowering speed or keeping
appropriate distance. Furthermore, patients might compensate
on a strategic level for example by adequate planning of a trip,
avoiding rush hours or using automatic gear shift (8). The known
fatigue problems in CD patients can also hamper their driving
abilities (9). Currently there is no literature available on driving
performance in CD.
A safe and standardized objective method to determine
driving performance is with a driving simulator which enables
to study real time driving performance and driving strategies
in a controlled environment (7, 10). Driving performance is a
concept that refers to the ability of a person to safely navigate a
driving vehicle through traffic and can vary for different traffic
situations. It can be measured by different outcomes such as
vehicle control, speed adaptations to different traffic situations,
distance control between the driver, and other traffic or gap
acceptance time for crossing intersections or merging onto
adjacent lanes. A subjective judgement of a participant’s driving
performance is the self-reporting questionnaire Fitness To Drive
Screening (FTDS or previously called the Safe Driving Behavior
Measure) (11). Based on the indications by patients in the clinical
practice and the limitations in performing daily life activities, it is
hypothesized that the operational driving skills are impaired and
that CD patients have more difficulties in controlling the vehicle.
To compensate for these impairments patients, when compared
to healthy controls, might drive more carefully by lowering their
speed, keeping more distance to a car in front or selecting a larger
gap between approaching cars when crossing an intersection. It
is also hypothesized that patients experience more fatigue and
have to make more effort to drive safely compared to healthy
controls. The main goal of this pilot study was therefore, to
explore objective driving performance and the subjective driving
evaluation (measured by the FTDS) in a small group of persons
with CD and to compare it to healthy controls.
METHODS
Study Design
The study was performed as an explorative between
group comparison.
Participants
Ten CD patients were recruited from the neurology department
of the University Medical Center Groningen with the following
inclusion criteria: idiopathic CD, 30 years or older, stable on
BoNT treatment for over a year, holding a valid drivers’ license
and being an active driver. Participants were excluded if they had
secondary or hereditary forms of dystonia, dystonia in other body
parts than the neck, if they had had deep brain stimulation or
selective nerve denervation for the treatment of their dystonia,
suffered from other neck conditions or used medication that
could affect driving performance. Healthy controls, matched
for age and gender, holding a valid drivers’ license, and active
drivers were recruited among hospital staff and their relatives.
Eligible participants had to understand the spoken and written
Dutch language.Written informed consent was obtained from all
participants. This study was approved by the local medical ethics
committee (METC number 2013/507).
Procedures
Data Collection
Measurements were performed 4–8 weeks after BoNT injections.
With an average working period of 12 weeks and a peak effect
between 2 and 6 weeks after injections, we expected an average
effect of the BoNT injections (12).
Themain parameters, driving performance and driving safety,
were derived from a validated fixed based driving simulator
located at the UniversityMedical Center Groningen (ST Software
Simulator Systems) (13). The simulator consisted of a projection
screen stage and an open cabin mock-up standing within this
stage and containing a force-feedback steering wheel, accelerator,
clutch, brake pedals, and audio sound simulated driving sound.
The projection screen stage held three video projectors and
three large flat-screens of 4.5m length, bent 60 degrees inwards,
which presented the participants with a 180 degrees horizontal
view. Front and side windows as well as a rear view mirror
and side mirrors were projected onto the screen. The simulator
software rendered virtual road environments simulating real
world road environments and traffic situations. Data of all
relevant parameters were recorded at a rate of 10Hz. Data was
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processed and stored in binary data files which were exported to
SPSS 24.0 for further analysis.
Driving Tasks in the Simulator
Participants performed three types of rides to assess various
aspects of driving performance; a lane tracking ride, an
intersection ride, and amerging ride. Participants were instructed
to drive as they would normally do. The average duration of the
lane tracking ride was 5min, of the intersection ride 7min, and
of the merging ride 3min on average. Shifting was automatically
controlled in all rides. Each ride was performed twice, with the
first ride to get the participants familiarized with the simulator
and traffic situations. Data from the second rides were used for
the analysis.
The lane tracking practice ride was in a rural area on a road
with alternating left-right curves of 40 degrees and 500m radius
and a continuous stream of traffic from the opposing direction
but no traffic on the lane of the simulator driver. The speed was
regulated by the computer and increased stepwise from 50 km/h
up to 100 km/h. The test ride was similar to the practice ride with
the difference that participants had to control the speed their
selves. First participants had to drive with a comfortable speed
after which they were asked to drive as if they were in a hurry.
During the intersection rides subjects were confronted
with six intersections with different regulations of right-of-
way. Participants were always driving straight ahead on the
intersections. Speed limits on traffic signs varied between 60 and
80 km/h and participants were asked to apply general traffic rules.
The first and sixth intersections were unmarked with traffic
coming from the right and left. In the Netherlands, cars drive on
the right side of the road and traffic coming from the right has
right of way. The second intersection was also unmarked with
traffic only coming from the right so the participant had to give
way. The third intersection was unmarked with traffic coming
from the left so the participants had right of way. The fourth
intersection wasmarked with a traffic light and participants could
continue driving when it turned green. The fifth intersection
was marked with a give way sign with traffic coming from the
right and left. After the fifth intersection an unexpected event
occurred. A parked car pulled out of the parking lot onto the
drive way so the participants had to break to avoid a collision.
For the analyses intersections 1, 2, 5, and 6 were selected in which
subjects had to determine when it was safe to cross (gap distance)
by observing the environment in various directions requiring
(a combination of) head movements, trunk movements, and
eye movements.
The last ride was a merging ride. First subjects needed to
merge on the right lane of a highway. Subsequently they had to
overtake a car where after they had to return to the right lane.
Finally they had to leave the highway and park the car at the side
of the road.
Driving in a simulator can provoke motion sickness.
Participants were instructed to indicate if they were feeling
sick during the driving tasks. If symptoms such as dizziness
or nausea were reported or observed, participants were advised




The Tsui scale was used to determine the severity of dystonia (14).
The Tsui scale measures different aspects of abnormal posture
and movement in CD patients. It has a max score of 25 point
where higher scores indicate higher levels of severity.
Perceived muscle fatigue in the neck area and driving effort
was rated just after the start and just before the end of the
simulated drive in order to determine the effects of drive duration
on driving performance, using the Borg CR-10 scale (15). The
Borg CR-10 scale is a reliable and validated scale 11 point rating
scale, ranging from 0 to 10 onwhich perceived fatigue and driving
effort during the performance of a task can be monitored. For
perceived fatigue a score of 0 means that a patient has no muscle
fatigue or discomfort in the neck area at all and a score of 10
means there is very much muscle fatigue or discomfort in the
neck area. In driving effort a score of 0 means that driving does
not require any effort while a score of 10 means that it requires
very much effort.
Fitness To Drive Screening Questionnaire
Self-perceived fitness to drive was measured with the Fitness To
Drive Screening questionnaire (FTDS). The FTDS questionnaire
(formerly known as the Safe Driving Behavior Measure) is a self-
report questionnaire related to driving fitness, driving behavior
and driving safety with a good reliability (ICC.253, p< 0.001) (11,
16). The FTDS has three sections: Section A, Demographics or
general information about the driver; Section B, Driving history
profile; and Section C, Ratings of driving difficulty pertaining to
54 driving skills. Difficulty of the driving task was rated with a 5-
point Likert scale (ranging from 1= extremely difficult to 5= not
difficult at all). Amean score was calculated for each individual by
summing up all scores divided by the number of items endorsed.
Simulator Outcomes
Lane tracking ride
The main measure to assess driving performance in the lane
tracking ride was the standard deviation of lateral position
(SDLP). The SDLP is the primary outcome for vehicle control
and measures the weaving of a car during driving (17). SDLP
is considered as the golden standard of driving performance in
driving simulators with high test–retest reliability (17).
The SDLP was assessed twice, once for the speed of choice
section (SDLP choice) and once for the section participants were
asked to drive in a hurry (SDLP hurry). Additional outcomes
were average speed, the number of collisions, and percentage of
line crossings on either side of the road during each ride.
Intersections ride
The main outcome to measures driving performance in the
intersection ride were gap distance left and right. Gap distance
left and right is defined as the shortest distance from an
approaching car coming from the left or right measured in
meters. The shorter the distance between the approaching car and
the subject, the more risk he or she took to cross the intersection.
This also applied for traffic coming from the left which has to
give right of way in the Netherlands on unmarked intersections.
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Traffic coming from the left was programmed to stop to let the
subject pass. However, it was also programmed to continue to
drive if a subject waited too long.
Additional outcomes on the intersections ride were the lowest
speed when approaching the intersection, average deviation from
the speed limit and the number of collisions.
Merging
In the merging ride the main parameter to measure driving
performance was deceleration of the rear car. Deceleration
of the rear car was defined by how fast the car behind
the participant had to break once a subject merged on
the adjacent lane. Deceleration of the rear car depended
on distance between the merging and rear car, absolute
speed of the rear car and differential speed between the
merging and rear car. A larger deceleration of the rear
car can be interpreted as a larger risk being taken by the
merging car.
Additional outcomes on themerging ride were the speed while
merging and rear time headway. Rear time headway was the
distance measured in seconds between the subject and car behind
the subject once merged on to the adjacent lane. The smaller the
time to headway the more risk a participant took to merge.
Statistical Analysis
First, descriptive statistics (frequencies, means and standard
deviations) for patient characteristics were calculated.
Based on the small sample size and unevenly distributed data
a Mann–Whitney U was performed to determine differences on
simulator outcomes and self-perceived fitness to drive between
the patient and control group. To determine the changes in
fatigue of the subjects within each group during the driving tasks,




A total of 11 patients and 14 controls were included. However,
one patient and four controls had to stop the simulator drives
due to motion sickness and were excluded from further analysis.
Mean age of the remaining 10CD patients (5 females, 5 males)
had a mean age of 56.8 years (SD 7.7, range 47–69) and a
mean disease duration of 15.1 years (SD 11.7, range 1–36 years).
Patients showed an average score of 9.7 (SD, 3.1, range 5–14)
for the severity of dystonia as measured with the Tsui scale All
patients showed a combination of deviating head postures. Eight
patients had a rotational component as main direction of the
deviating posture (4 patients rotated the left and 4 to the right).
Two patients showed a laterocollis as main component of their
deviating posture (1 patient had a laterocollis to the left and 1 to
the right). The control group existed of 10 persons (6 females, 4
males) with a mean age of 57.3 years (SD 7.4, range 48–67) which
were matched for age and gender. Characteristics for each group
are described in Table 1.










56.8 (7.7, 47–69) 57.3 (7.4, 48–67) 0.747






























Car accidents in last
year
0* 0* 1.000
Traffic fines in last year
Total (range)
1 (0–1) 10 (0–3)* 0.028**
NA, Not Applicable.
*For 9 out of 10 cases because one did not report the information.
**Significant at the < 0.05 level.
Simulator Rides
On the speed of choice section of the lane tracking ride, no
significant differences were found on the SDLP. Patients showed
a median SDLP of 27.60 cm (range 15.80–35.70) compared to
25.90 cm (range 21.30–43.00) in controls (p = 0.853). None
of the other outcomes, except the percentage of line crossings
on the right side of the road, showed significant differences
either. Healthy controls had a significant higher percentage of
line crossings than patients. Patients had a median of 0.00
(range 0.00–9.20) percent of the time that they crossed the line
compared to a median of 2.30 (range 0.00–37.00) percent of the
time in controls (p = 0.043). There were no line crossing at the
left side of the road.
On the speed in hurry section of the lane tracking ride,
none of the outcomes showed significant differences. Patients
showed a median SDLP of 28.40 cm (range 20.30–39.70) vs.
31.50 cm (range 21.10–37.80) for healthy controls (p = 0.684).
An overview of median scores and ranges for all the outcomes
and the between group differences are displayed in Table 2.
On the intersections ride no significant differences were found
on any of the outcomes. On intersection 1 median gap distance
with traffic from the left was 2.78 meters (range 1.00–174.44)
for patients vs. 1.29 meters (range 1.00–164.00) for controls
(p = 1.000). Median gap distance with traffic from the right was
90.64 meters (range 3.15–107.23) for patients and 72.84 meters
(range 5.07–123.85) for controls (p = 0.226). On intersection 2
traffic was only coming from the right. Patients showed a median
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TABLE 2 | Median scores, ranges, and between group difference for driving performance and driving safety.
Outcome Patients (N = 10)i
median (range)






SDLP in cm 27.60 (15.80–35.70) 25.90 (21.30–43.00) 0.853
% line crossings
Left (0.00–0.30) (0.00–0.00) 0.739
Right (0.00–9.20) 2.30 (00–37.00) 0.043*
Nr. of collisions 0 0 NA
Average speed in km/h 79.45 (55.60–86.60) 73.20 (58.00–82.10) 0.280
Speed in hurry
SDLP in cm 28.40 (20.30–39.70) 31.50 (21.10–37.80) 0.684
% line crossings
Left (0.00–0.60) (0.00–0.00) 0.739
Right (0.00–10.20) 0.70 (0.00–16.20) 0.280
Nr. of collisions 0 0 NA
Average speed in km/h 91.05 (62.90–101.30) 88.60 (74.90–99.70) 0.481
Intersections ride
Gap left int 1 in m 2.78 (1.00–178.44) 1.29 (1.00–164.00) 1.000
Gap left int 2 in m NA NA NA
Gap left int 5 in ma NA NA NA
Gap left int 6 in m 1.00 (0.99–8.00) 1.00 (1.00–153.65) 0.741
Gap right int 1 in m 90.64 (3.15–107.23) 72.84 (5.07–123.85) 0.226
Gap right int 2 in mb 191.66 (16.29–291.78) 93.92 (7.91–218.66) 0.602
Gap right int 5 in mc NA NA NA
Gap right int 6 in m 101.92(2.40–110.67) 98.01 (16.97–138.11) 0.650
Minimum speed int 1 in km/h (0.00–7.57) 6.00 (0.00–25.49) 0.084
Minimum speed int 2 in km/h 5.17 (1.00–7.79) 4.84 (0.76–7.48) 0.806
Minimum speed int 5 in km/h (0.00–0.83) (0.00–0.00) 0.168
Minimum speed int 6 in km/h 2.73 (0.00–6.78) 6.90 (0.00–8.17) 0.070
Deviation from speed limit 60 km/h 1.02 (−5.01–12.81) 2.39 (−5.21–17.26) 0.791
Deviation from speed limit 80 km/h −6.99 (−31.23–8.21) −8.75 (−20.83–0.92) 0.734
Nr. of collisions 0 0 NA
Merging ride on highway
Merging
Deceleration rear car merging in km/h (0.00–0.10) 0.00(−0.20–0.00) 0.169
Speed while merging in km/h 92.50 (88.00–100.70) 97.50 (85.00–111.20) 0.566
Rear time to headway merging in s 1.40 (0.20–2.40) 1.50 (0.20–2.20) 0.965
Overtaking
Deceleration rear car overtaking in km/h −4.30 (−6.70
to −0.80)
−5.30(−8.00 to −4.00) 0.216
Speed while overtaking in km/h 98.60 (91.50–103.00) 95.60 (91.60–99.70) 0.566
Rear time to headway overtaking in s 0.70 (0.40–1.00) 0.80 (0.20–0.90) 0.559
Minimum time headway overall in s 0.20 (0.13–0.33) 0.28 (0.10–0.42) 0.185
SDLP, Standard Deviation of the Lateral Position on the road; NA, Not Applicable.
*Significant at the P < 0.05 level.
aEight patients and eight controls waited until all oncoming traffic passed before crossing the intersection so gap distance and statistical difference could not be calculated.
bMedians, ranges and significance are based on data from 5 patients and 5 controls. Remaining participants waited until all oncoming traffic passed before crossing the intersection so
gap distance could not be calculated.
cNine patients and nine controls waited until all oncoming traffic passed before crossing the intersection so gap distance and statistical difference could not be calculated.
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distance of 191.66 meters (range 16.29–291.78) and controls
93.92 meters (range 7.19–218.66) (p = 0.602). On intersection
5 traffic was coming from the left and right where subjects had
to give right of way. The majority of the subjects waited until all
traffic had passed before crossing the intersection. Eight patients
and eight controls waited until all the traffic from the left had
passed before crossing the intersection. Nine patients and nine
controls waited until all the traffic from the right had passed. Gap
distance and statistical differences between the groups could not
be calculated for these subjects because there was no gap distance
since all the approaching cars had already passed. For these
participants gap distance was recorded as a missing value. On
intersection 6 median gap distance with traffic from the left was
1.00 meters (range.99–8.00) for patients vs. 1.00 meters (range
1.00–153.65) for controls (p = 0.741). Median gap distance with
traffic from the right was 101.92 meters (range 2.40–110.67)
for patients and 98.01 meters (range 16.97–138.11) for controls
(p= 0.650).
It was noticeable however that both patients and controls
drove with speeds well under the speed limit on the sections
where a speed of 80 km/h was allowed (patients median
speed 6.99 km/h under the speed limit (range 31.23 km/h under
speed limit to 8.21 km/h above speed limit) and controls median
speed 8.75 km/h under the speed limit (range 20.83 km/h under
speed limit to 0.92 km/h above speed limit), p= 0.734).
On the merging ride no significant differences were found on
the primary outcome deceleration of the rear car, nor on any
of the other additional outcomes. Median deceleration of the
rear cars was 0.00 for both patients and controls during merging
on the highway (range 0.00–0.10 for patients vs. range −0.20–
0.00 for controls, p = 0.169). During overtaking rear cars had to
decelerate with amedian of−4.30 km/h for patients (range−6.70
to −0.80) and for controls with a median of −5.30 km/h (range
−8.00 to−4.00, p= 0.216).
Self-Perceived Fatigue and Driving Effort
For self-perceived fatigue, patients showed amedian fatigue score
of 1.5 at the start of the lane tracking (range= 0.00–6.00) and also
1.5 after finishing (range = 0.00–7.00). For controls a median
score of 0.00 was found at the start (range = 0.00–0.00) and











• Start of the ride(range) 1.5 (0–6) 0 (0–0) 0.005* Patients: 0.593
• Finish (range) 1.5 (0–7) 0 (0–5) 0.033* Controls: 0.317
• Change score (range) 0 (−3–6) 0 (0–5) 0.957
Borg driving effort
• Just after start (range) 1 (0–6) 2.5 (0–7) 0.377 Patients: 0.892
• Just before finish (range) 1 (0–7) 2.5 (0–7) 0.419 Controls: 1.000
• Change score (range) 0 (−3–6) 0 (0–0) 0.619
Intersections ride
Borg perceived fatigue
• Start of the ride (range) 1 (0–5) 0 (0–6) 0.051 Patients:0.257
• Finish (range) 2 (0–6) 0 (0–6) 0.095 Controls:0.317
• Change score (range) 0 (−1–4) 0 (0–2) 0.619
Borg driving effort
• Just after start (range) 2.5 (0–7) 4 (0–8) 0.515 Patients:0.317
• Just before finish (range) 2.5 (0–8) 4 (0–8) 0.492 Controls: 1.000
• Change score (range) 0 (−1–1) 0 (0–0) 0.278
Merging ride on Highway
Borg perceived fatigue
• Start of the ride (range) 1 (0–4) 0 (0–5) 0.400 Patients:0.655
• Finish (range) 1 (0–5) 0 (0–5) 0.220 Controls:0.317
• Change score (range) 0 (−1–4) 0 (−3–0) 0.563
Borg driving effort
• Just after start (range) 1 (0–5) 2 (0–8) 0.332 Patients: 1.000
• Just before finish (range) 1 (0–5) 2 (0–8) 0.332 Controls: 1.000
• Change score (range) 0–(0–0) 0 (0–0) 1.000
FTDS (range) 0.33 (0.01–0.96) 0.21 (0.00–0.74) 0.178
FTDS, Fitness To Drive Screening.
*Significant at the P < 0.05 level.
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a median score of 0.00 after finishing the ride (range = 0.00–
5.00). Differences were significantly higher for patients at the
start (p = 0.005) and finish (p = 0.033) of the lane tracking ride,
indicating higher levels of fatigue. Although none of the other
rides showed significant differences between the groups on self-
perceived fatigue, the start of the intersections ride showed a near
significant difference (p = 0.051) indicating increasing fatigue
levels for control subjects during the course of the simulator
rides. Neither the patient nor control group showed significant
differences in change scores of fatigue before and after each
driving task.
A between comparison of the differences between self-
perceived fatigue before and after each driving task also did not
reveal significant differences on any of the simulator drives.
On the Borg scale for driving effort no significant differences
for between the group comparisons, nor for within group
comparisons were found for any of the simulator rides. An
overview of median scores, ranges, between group differences
and within group differences for self-perceived fatigue and
driving effort are displayed Table 3.
Self-Perceived Fitness to Drive
Self-perceived fitness to drive showed a median of individual
mean FTDS scores of 0.33 (range 0.01–0.96) for patients and
0.21 for controls (range 0.00–0.74). Group comparison of FTDS
scores revealed no significant difference (p= 0.178). An overview
of median scores, ranges and the between group differences for
the FTDS are displayed in Table 3.
DISCUSSION
In this explorative pilot study, patients with CD did not show
significant differences in driving performance as measured
with the SDLP on the lane tracking ride, gap distance on
the intersections ride and deceleration of the rear car on the
merging ride compared to controls. On intersection 5, where the
participants had to give way, all but two patients and two controls
waited until all approaching traffic had passed before crossing the
intersection. Therefore, no gap distance and statistical differences
between the groups could be calculated. However, this finding
indicates that both patients and controls took no risk with
crossing the intersection.
On the additional outcomes, the percentage of line crossings
on the right side of the road was significantly higher in healthy
controls in the first lane tracking ride, but no differences in line
crossings were found between groups in any of the following
rides. Self-perceived fatigue was significantly higher for patients
compared to controls at the start and finish of the lane tracking
ride, but this group difference was not significant in the other
driving tasks. No differences between the groups were found in
self-perceived fitness to drive.
It was remarkable that no significant differences were found
in driving performance in the simulator between the groups,
since many patients indicate having trouble with different
practical aspects of driving. Patients reported to avoid certain
traffic situations like rush hours, bad weather and driving long
distances. Patients also indicated that they use tricks while driving
in their car such as supporting their head while driving or turning
their entire torso to oversee oncoming traffic before crossing an
intersection. It was hypothesized that patients would compensate
for their physical limitations by driving more carefully and
slowly. Studies on compensatory driving behavior indicate that
elderly and neurological patients tactically compensate for their
limitations by driving slower, increasing the distance to the car
in front, waiting longer at intersections, and selecting larger
time gaps between the passing cars for merging (13, 18–
20). This hypothesis is supported by the patient characteristics
were healthy controls had significant more traffic fines mainly
for violating the speed limit. The adaptations described in
the studies on compensatory driving behavior in elderly and
neurological patients were however not observed in the present
experiment. This could possibly be explained by overcautious
driving behavior in both groups. For example; nine out of ten
subjects in each group waited until all traffic coming from the
right had passed and drove below the maximum speed while
approaching intersection 5 on the intersections ride. It could
also be explained by the fact that subjects drove in a research
setting where they were watched so they tended to apply the
traffic rules much better and gave right of way to anyone coming
from the right side. Amore general assessment of risk behavior as
a personality trait at baseline could have been valuable to exclude
that differences in risk behavior may have influenced the results.
Another possible explanation for not finding significant
differences on these outcomes is that measurements were
performed 4–8 weeks after BoNT injections. With an average
working period of 12 weeks and a peak effect between 2 and
4 weeks after injections, we expected an average effect of the
BoNT injections. BoNT injections are the treatment of choice
in CD, and most patients respond well to treatment which
decreases dystonic activity (6). Therefore patients did not have
to compensate for the dystonic movements as much and might
not have experienced sufficient functional limitations to apply
compensatory behavior.
Another possible explanation for not finding significant
differences is that CD patients have good coping strategies.
CD patients may compensate for impaired control of head
movements by moving their eyes or torso instead of their heads
while looking for oncoming traffic. Future studies should therefor
integrate methods to measure eye movements, gaze behavior, and
head movements with the simulator rides to test this hypothesis.
Furthermore, the simulator rides were relatively short. This study
did not investigate driving performance with prolonged driving,
which patients with CD report as problematic. Therefore, the
simulator rides were possibly too short to provoke any differences
between the groups.
We did find significant differences between groups in fatigue
at the start and end of the lane tracking ride. These findings are
in line with a study by Smit et al. (3) that showed significant
higher levels of fatigue in CD patients measured with the Fatigue
Severity Scale compared to health controls. Fatigue, however, did
not increase significantly more during the simulator drives in CD
patients compared to healthy controls.
The effects of BoNT therapy could explain why there was no
significant increase in fatigue during the driving tasks. Due to the
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decreased dystonic activity in the affectedmuscles, patients might
not have had to compensate for the dystonic movements as much
and did not experience a significant increase in fatigue during the
driving tasks.
Because this study was an explorative pilot study, there were
some limitations.
First of all, the sample size was small so no firm conclusions
can be made based on the findings in this study. Secondly, the
simulator rides were relatively short and no measures for head
or eye movement and gaze direction were incorporated meaning
that compensations on this level could not be recorded.
In conclusion, this study compared driving performance
between patients with CD and healthy controls on a lane tracking
ride, an intersections ride and a merging ride on a highway
with a driving simulator. No indications were found that driving
performance was significantly different in CD patients compared
to healthy controls. However, future studies with larger groups
and longer simulator scenarios in which head and eye trackers
are applied should be performed to investigate whether these
findings can be replicated and to what extent patients compensate
for impaired control of head movement. Furthermore, adding
groups of patients which are examined during different time
points in the BoNT cyclus would be worthwhile to investigate the
effect of CD on driving performance in patients with different
effects of BoNT.
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